EPA 2012-07-02 22:37:02 GlaxoSmithKline fined USD 3 billion for fraud
A 26 June 2000 handout photo from drug maker GlaxoSmithKline PLC shows the company's corporate offices in Philadelphia, Pennsylvania, USA. GSK has reportedly has been hit with a USD 3 billion fine by the US Justice Department and will plead guilty to misbranding drugs Paxil and Welbutrin into interstate commerce. According to the government the drugs were marketed for afflictions for which they had not been approved. The fine is the larges payment by a US drug manufacturer and the largest fraud settlement in US history. EPA/GLAXOSMITHKLINE HANDOUT EDITORIAL USE ONLY NO SALES
© Copying and using the photographs in any manner and in any amount without a written permit from agency LETA is prohibited. Unauthorized use of images may violate copyright laws. LETA, its photographers or photo partners hold all the rights to the photographs published here. Information contained at http://www.leta.lv is protected in accordance with the laws and regulations of the Republic of Latvia, including the copyright laws.